Progress on the Neuroscience-Based Nomenclature (NbN) for Psychotropic Medications.
作者信息
Blier Pierre, Oquendo Maria A, Kupfer David J
机构信息
Departments of Psychiatry and Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
Columbia Psychiatry, Columbia University, New York, NY, USA.
出版信息
Neuropsychopharmacology. 2017 Sep;42(10):1927-1928. doi: 10.1038/npp.2017.33. Epub 2017 Feb 9.
Abstract
摘要
相似文献
1
Progress on the Neuroscience-Based Nomenclature (NbN) for Psychotropic Medications.基于神经科学的精神药物命名法（NbN）的进展。
Neuropsychopharmacology. 2017 Sep;42(10):1927-1928. doi: 10.1038/npp.2017.33. Epub 2017 Feb 9.
2
The Neuroscience-based Nomenclature Child & Adolescent (NbN C&A) for Psychotropic Medications: Innovation in Progress.基于神经科学的精神药物命名儿童和青少年版（NbN C&A）：创新进行中。
J Am Acad Child Adolesc Psychiatry. 2022 Nov;61(11):1317-1318. doi: 10.1016/j.jaac.2022.06.002. Epub 2022 Jun 10.
3
A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.精神药物当前命名法综述及基于神经科学的命名法介绍。
Eur Neuropsychopharmacol. 2015 Dec;25(12):2318-25. doi: 10.1016/j.euroneuro.2015.08.019. Epub 2015 Sep 7.
4
Editorial: Neuroscience-based Nomenclature (NbN) replaces the current label of psychotropic medications in European Psychiatry.社论：基于神经科学的命名法（NbN）取代了欧洲精神病学中目前精神药物的标签。
Eur Psychiatry. 2017 Feb;40:123. doi: 10.1016/j.eurpsy.2016.07.009. Epub 2016 Dec 30.
5
[Newly developed nomenclature (Neuroscience-based Nomenclature)].[新制定的命名法（基于神经科学的命名法）]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2016 Jun;36(3):69-71.
6
Neuroscience-Based Nomenclature (NbN): the Portuguese version of the new classification for psychopharmacological drugs.基于神经科学的命名法（NbN）：精神药理学药物新分类的葡萄牙语版本。
Trends Psychiatry Psychother. 2024 Jan 18. doi: 10.47626/2237-6089-2023-0771.
7
A Neuroscience-Based Nomenclature (NbN) for Psychotropic Agents.基于神经科学的精神药物命名法（NbN）
Int J Neuropsychopharmacol. 2016 Aug 12;19(8). doi: 10.1093/ijnp/pyw066. Print 2016 Aug.
8
Neuroscience-based nomenclature (NbN).基于神经科学的命名法（NbN）。
Lancet Psychiatry. 2017 Apr;4(4):272-273. doi: 10.1016/S2215-0366(17)30098-6.
9
Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications.基于神经科学的命名法（jNbN）取代精神药物的传统术语。
Eur Arch Psychiatry Clin Neurosci. 2016 Aug;266(5):385-6. doi: 10.1007/s00406-016-0699-0.
10
Neuroscience-based Nomenclature (NbN) for Clinical Psychopharmacology and Neuroscience.临床精神药理学与神经科学的基于神经科学的命名法（NbN）
Clin Psychopharmacol Neurosci. 2016 May 31;14(2):115-6. doi: 10.9758/cpn.2016.14.2.115.
引用本文的文献
1
Efficacy and Safety of KarXT (Xanomeline-Trospium; Cobenfy™) in Schizophrenia: A Systematic and Meta-Analysis Review of Randomized Controlled Trials.KarXT（Xanomeline-曲司氯铵；Cobenfy™）治疗精神分裂症的疗效与安全性：随机对照试验的系统评价与荟萃分析
Psychiatr Q. 2025 Oct 4. doi: 10.1007/s11126-025-10226-7.
2
Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment.当前 KarXT（盐酸二甲苯噻嗪-托吡酯）治疗精神分裂症的研究结果及潜在机制。
Clin Drug Investig. 2024 Jul;44(7):471-493. doi: 10.1007/s40261-024-01377-9. Epub 2024 Jun 21.
3
Innovations in Psychopharmacology Education in U.S. Psychiatric Residency Programs.美国精神科住院医师培训项目中的精神药理学教育创新。
Focus (Am Psychiatr Publ). 2021 Jan;19(1):46-49. doi: 10.1176/appi.focus.20200037. Epub 2021 Jan 25.
本文引用的文献
1
A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.精神药物当前命名法综述及基于神经科学的命名法介绍。
Eur Neuropsychopharmacol. 2015 Dec;25(12):2318-25. doi: 10.1016/j.euroneuro.2015.08.019. Epub 2015 Sep 7.
2
Classifying psychotropic drugs by mode of action and not by target disorder.根据作用方式而非目标疾病对精神药物进行分类。
CNS Spectr. 2013 Jun;18(3):113-7. doi: 10.1017/S1092852913000308.
3
Beyond psychoanaleptics - can we improve antidepressant drug nomenclature?除了精神兴奋剂之外——我们能否改进抗抑郁药物的命名？
J Psychopharmacol. 2009 Jun;23(4):343-5. doi: 10.1177/0269881109105498.
Zotero 插件